Inactive Instrument

All News United Gene High-Tech Group Ltd Hong Kong S.E.

Equities

0399

KYG9235H1294

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	Jun. 28	CI
Innovative Pharmaceutical Renews THU Agreement, Revises Product's Commercialization Timeline	Jun. 26	MT
Innovative Pharmaceutical Biotech Limited Provides Update on the Status of the Commercialization of the Oral Insulin Product (The "Product") and the Latest Business Development of the Group	Jun. 25	CI
Innovative Pharmaceutical Biotech Limited announced that it has received HKD 55.5 million in funding	Jun. 20	CI
Innovative Pharma Extends Long Stop Date for Convertible Bond Issuance	May. 31	MT
Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit	Nov. 30	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 29	CI
Innovative Pharmaceutical Biotech to Return to Profit in Fiscal H1	Nov. 28	MT
Innovative Pharmaceutical Biotech Limited Provides Unaudited Earnings Guidance for the Six Months Ended 30 September 2023	Nov. 27	CI
Innovative Pharmaceutical Biotech Limited Announces Change of Address of Principal Place of Business in Hong Kong	Nov. 07	CI
Innovative Pharmaceutical Eyes Majority Stake in US Neurotechnology Firm	23-09-05	MT
Innovative Pharmaceutical Biotech Limited entered into a memorandum of understanding to acquire a majority interest in Niraxx Light Therapeutics, Inc.	23-09-03	CI
Innovative Pharmaceutical Plans HK$55.5 Million Bond Issue	23-07-28	MT
Innovative Pharmaceutical to Raise HK$58 Million From Deal with US Firm Genuine Marketing	23-07-27	MT
Innovative Pharmaceutical Biotech Limited announced that it expects to receive HKD 55.5 million in funding	23-07-26	CI
Innovative Pharmaceutical Biotech Limited Appoints Cheng Tak Yiu as an Executive Director	23-07-04	CI
Innovative Pharmaceutical Biotech Incurs Loss in Fiscal Year 2023	23-06-29	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-29	CI
Innovative Pharmaceutical Biotech Mulls Over Capital Injection in Technical Services Company	23-01-20	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News United Gene High-Tech Group Ltd Hong Kong S.E.

Equities

0399

KYG9235H1294

All News

Filters